Sequential antibiotic therapy: Effective cost management and patient care

Area of Science:

• Pharmacology
• Infectious Diseases
• Health Economics

Background:

• Rising antimicrobial chemotherapy costs impact healthcare providers and patients.
• Strategies to mitigate these costs are actively sought.
• Sequential antibiotic therapy (SAT) is a key cost-saving approach.

Purpose of the Study:

• To critically review the evidence supporting sequential antibiotic therapy (SAT).
• To evaluate the advantages and disadvantages of SAT.
• To discuss the implementation of SAT programs in hospitals.

Main Methods:

• Literature review of randomized controlled trials (RCTs) on SAT.
• Analysis of economic, patient, and healthcare provider benefits.
• Identification of potential risks and implementation challenges.

Main Results:

• Evidence from RCTs supports the efficacy and benefits of SAT.
• SAT demonstrates economic advantages and benefits for patients and providers.
• Potential disadvantages include consumer cost and risk of therapeutic failure.

Conclusions:

• SAT is a viable strategy supported by clinical evidence.
• Further research is required to optimize IV-to-oral transition timing.
• Identifying factors influencing oral drug efficacy is crucial for successful SAT implementation.